(Q46034947)

18 December 2017

title

Hormone replacement therapy and breast cancer risk in California. (English)

1 reference

18 December 2017

Hormone Replacement Therapy

main subject

California

0 references

1 reference

Nathan J Coombs

1

1 reference

18 December 2017

Richard Taylor

2

1 reference

18 December 2017

Nicholas Wilcken

3

1 reference

18 December 2017

James Fiorica

4

1 reference

18 December 2017

John Boyages

5

1 reference

18 December 2017

publication date

1 November 2005

1 reference

18 December 2017

published in

The Breast Journal

1 reference

18 December 2017

volume

11

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

410-415

1 reference

18 December 2017

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Evidence from randomised trials on the long-term effects of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Personal use of postmenopausal hormone replacement therapy by women physicians in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

HRT and breast cancer: impact on population risk and incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

The Million Women Study: potential biases do not allow uncritical acceptance of the data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.00132.X

10.1111/J.1075-122X.2005.00132.X

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017